NRC — National Research Cashflow Statement
0.000.00%
- $244.26m
- $302.73m
- $143.06m
- 86
- 72
- 26
- 65
Annual cashflow statement for National Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 37.3 | 37.5 | 31.8 | 31 | 24.8 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.617 | 0.94 | 4.27 | 1.34 | 0.642 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4.61 | 1.84 | -3.35 | 1.02 | 3.84 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 40.6 | 46.3 | 36.3 | 38.1 | 34.6 |
Capital Expenditures | -3.98 | -5.51 | -9.84 | -15.8 | -15.4 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.26 | -3 | — | 0.001 | -4.83 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3.72 | -8.51 | -9.84 | -15.8 | -20.3 |
Financing Cash Flow Items | -2.82 | -0.721 | -2.23 | -0.008 | -0.359 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -15.5 | -18.2 | -55.6 | -40.7 | -16.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 21.2 | 19.7 | -29.3 | -18.4 | -2.42 |